ConductScience.org, home

Paper23698397

Suppression of coronavirus replication by cyclophilin inhibitors.

Tanaka Y and 2 others. Viruses, 2013. Cited by 126 papers, by iCite.

Cite this record

ConductScience Library. Suppression of coronavirus replication by cyclophilin inhibitors. Papers, record 23698397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23698397

Download JSON
Disease
COVID-19540 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Suppression of coronavirus replication by cyclophilin inhibitors.
PubMed
Journal
Viruses
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
126
iCite
Relative citation ratio, by iCite
3.84
iCite
Revised in PubMed
2021-10-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tanaka YYoshikazu
2Sato YYuka
3Sasaki TTakashi

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
CoronavirusMajor topic
CyclophilinsMajor topic
CyclosporineMajor topic
Host-Pathogen InteractionsMajor topic
Virus ReplicationMajor topic

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04540926Cyclosporine A Plus Low-steroid Treatment in COVID-19 PneumoniaResults

Source ClinicalTrials.gov

Download CSV of trials

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115688292Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus.J Infect Dis2005https://conductscience.org/library/papers/15688292PubMed
216051301Mutagenesis of the murine hepatitis virus nsp1-coding region identifies residues important for protein processing, viral RNA synthesis, and viral replication.Virology2005https://conductscience.org/library/papers/16051301PubMed
318667415The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition.J Biol Chem2008https://conductscience.org/library/papers/18667415PubMed
419932913Multiple cyclophilins involved in different cellular pathways mediate HCV replication.Virology2010https://conductscience.org/library/papers/19932913PubMed
522814107Cyclophilin A and viral infections.Biochem Biophys Res Commun2012https://conductscience.org/library/papers/22814107PubMed
620510744Contribution of Cyclophilin A to determination of simian immunodeficiency virus tropism: a progress update.Vaccine2010https://conductscience.org/library/papers/20510744PubMed
717696607Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines.PLoS Pathog2007https://conductscience.org/library/papers/17696607PubMed
821752960Cyclosporin A inhibits the replication of diverse coronaviruses.J Gen Virol2011https://conductscience.org/library/papers/21752960PubMed
919430490Coronaviruses post-SARS: update on replication and pathogenesis.Nat Rev Microbiol2009https://conductscience.org/library/papers/19430490PubMed
1012810862Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype.J Gen Virol2003https://conductscience.org/library/papers/12810862PubMed
1117715225Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain.J Virol2007https://conductscience.org/library/papers/17715225PubMed
128421688A cyclophilin-related protein involved in the function of natural killer cells.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8421688PubMed
139570313The 20kD protein of human [U4/U6.U5] tri-snRNPs is a novel cyclophilin that forms a complex with the U4/U6-specific 60kD and 90kD proteins.RNA1998https://conductscience.org/library/papers/9570313PubMed
147884893Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions.J Virol1995https://conductscience.org/library/papers/7884893PubMed
1511943775Active site residues of cyclophilin A are crucial for its signaling activity via CD147.J Biol Chem2002https://conductscience.org/library/papers/11943775PubMed
1620962430Cyclophilin A: promising new target in cardiovascular therapy.Circ J2010https://conductscience.org/library/papers/20962430PubMed
1721295323Emerging picture of host chaperone and cyclophilin roles in RNA virus replication.Virology2011https://conductscience.org/library/papers/21295323PubMed
1822546085Suppression of feline coronavirus replication in vitro by cyclosporin A.Vet Res2012https://conductscience.org/library/papers/22546085PubMed
1915579090Antiviral drugs that target cellular proteins may play major roles in combating HIV resistance.Curr Pharm Des2004https://conductscience.org/library/papers/15579090PubMed
2015989969Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.Mol Cell2005https://conductscience.org/library/papers/15989969PubMed

See all 48 referencesDownload CSV of references

Cited by108

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.

PMIDTitleJournalYearIn PapersSource
41702946Effectiveness and safety of cyclosporine A in moderate to severe COVID-19: a randomized, open-label trial.Sci Rep2026https://conductscience.org/library/papers/41702946PubMed
40867689Translating Antiviral Therapies to Veterinary Use: A Review of Immunomodulatory Agents for Potential Application in Aleutian Mink Diseases.Animals (Basel)2025https://conductscience.org/library/papers/40867689PubMed
39274454Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19: A Multicenter, Randomized Clinical Trial.J Clin Med2024https://conductscience.org/library/papers/39274454PubMed
39045055Cyclophilin inhibition as a strategy for the treatment of human disease.Front Pharmacol2024https://conductscience.org/library/papers/39045055PubMed
38313994A Retrospective and Comparative Analysis of Clinical Outcomes of Kidney Transplant Recipients During First and Second COVID-19 Waves in North-West India.Cureus2024https://conductscience.org/library/papers/38313994PubMed
38287815Potential Alternative Receptors for SARS-CoV-2-Induced Kidney Damage: TLR-4, KIM-1/TIM-1, and CD147.Front Biosci (Landmark Ed)2024https://conductscience.org/library/papers/38287815PubMed
37766254Feline Infectious Peritonitis: European Advisory Board on Cat Diseases Guidelines.Viruses2023https://conductscience.org/library/papers/37766254PubMed
37742314A brief overview of SARS-CoV-2 infection and its management strategies: a recent update.Mol Cell Biochem2024https://conductscience.org/library/papers/37742314PubMed
37304177The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness.Curr Dermatol Rep2023https://conductscience.org/library/papers/37304177PubMed
36986883An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro.Pharmaceutics2023https://conductscience.org/library/papers/36986883PubMed
36712291Cyclophilin A-mediated mitigation of coronavirus SARS-CoV-2.Bioeng Transl Med2023https://conductscience.org/library/papers/36712291PubMed
36531832Hepatic Disorders and COVID-19: From Pathophysiology to Treatment Strategy.Can J Gastroenterol Hepatol2022https://conductscience.org/library/papers/36531832PubMed
36187879Liver transplantation during COVID-19: Adaptive measures with future significance.World J Transplant2022https://conductscience.org/library/papers/36187879PubMed
36062268Impact of Living Donor Liver Transplantation on COVID-19 Clinical Outcomes from a Quaternary Care Centre in Delhi.J Clin Transl Hepatol2022https://conductscience.org/library/papers/36062268PubMed
36051937Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review.World J Crit Care Med2022https://conductscience.org/library/papers/36051937PubMed
35663540Pediatric transplantation during the COVID-19 pandemic.World J Transplant2022https://conductscience.org/library/papers/35663540PubMed
35568446Calcineurin Inhibitors and COVID-19.Reumatol Clin (Engl Ed)2022https://conductscience.org/library/papers/35568446PubMed
35369023A Comparison Study of Coronavirus Disease 2019 Outcomes in Hospitalized Kidney Transplant Recipients.Kidney3602021https://conductscience.org/library/papers/35369023PubMed
35187216Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients.Transplant Direct2022https://conductscience.org/library/papers/35187216PubMed
34985368COVID-19: General Strategies for Herbal Therapies.J Evid Based Integr Med2022https://conductscience.org/library/papers/34985368PubMed

See all 108 cited byDownload CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
CYCLOSPORINECHEMBL160Results1https://conductscience.org/library/drugs/CHEMBL160

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23698397

GET https://conductscience.org/api/papers/v1/23698397/references?page=2